Sunshine Act Meetings, 1094 [2024-00333]
Download as PDF
<![CDATA[
1094
Federal Register / Vol. 89, No. 6 / Tuesday, January 9, 2024 / Notices
(NAMs), to reduce, refine or replace
vertebrate animal testing and provide
information of equivalent or better
scientific quality and relevance for
assessing risks of injury to health or the
environment.
ADDRESSES: The docket for this action,
identified by docket identification (ID)
number EPA–HQ–OPPT–2023–0627, is
available online at https://
www.regulations.gov. Additional
instructions for visiting the docket,
along with more information about
dockets generally, is available at https://
www.epa.gov/dockets.
FOR FURTHER INFORMATION CONTACT: For
technical information contact: Renee
Beardslee, New Chemical Division
(7405M), Office of Pollution Prevention
and Toxics, Environmental Protection
Agency, 1200 Pennsylvania Ave. NW,
Washington, DC 20460–0001: telephone
number: (202) 564–8787; email address:
beardslee.renee@epa.gov.
For general information contact: The
TSCA-Hotline, ABVI-Goodwill, 422
South Clinton Ave., Rochester, NY
14620; telephone number: (202) 554–
1404; email address: TSCA-Hotline@
epa.gov.
SUPPLEMENTARY INFORMATION:
khammond on DSKJM1Z7X2PROD with NOTICES
I. Does this action apply to me?
This action is directed to the public
in general. This notice may be of
specific interest to persons who are or
may be interested in risk assessments of
new chemical substances under TSCA
(e.g., submitters of TSCA 5 notices,
industry, non-governmental
organizations (NGOs), and academia).
Since other entities may also be
interested, the Agency has not
attempted to describe all the specific
entities that may be affected by this
action.
II. What action is the Agency taking?
EPA is announcing the availability of
a new decision framework for use by the
New Chemicals Division (NCD) of the
Office of Pollution Prevention and
Toxics (OPPT) for identification of eye
irritation or corrosion hazards for new
chemical substances based on
prioritization of reproducible, humanrelevant data. The document supports
EPA’s efforts to develop NAMs that do
not require vertebrate animal testing and
furthers the agency’s commitment to
reduce and replace the use of vertebrate
animals in the testing of chemical
substances and mixtures.
TSCA section 4(h)(2)(A) directs EPA
to ‘‘promote the development and
implementation of alternative test
methods and strategies to reduce, refine,
or replace vertebrate animal testing and
VerDate Sep<11>2014
16:38 Jan 08, 2024
Jkt 262001
provide information of equivalent or
better scientific quality and relevance
for assessing risks of injury to health or
the environment.’’
To incorporate alternative test
methods and strategies, or NAMs, data
for eye irritation and corrosion hazard
identification into the new chemicals
program risk assessment process, NCD
developed a framework for new
chemical risk assessments that
prioritizes reproducible, humanrelevant in vitro data. The Framework is
based upon existing peer-reviewed
literature, accepted Organization for
Economic Cooperation and
Development (OECD) test guidelines,
and other existing accepted risk
assessment approaches.
NCD is responsible for conducting
risk assessments for new chemical
substances submitted under TSCA
section 5 authority. NCD expects
multiple benefits from the incorporation
of this proposed Framework in its
assessment including: (1) progress
towards fulfilling TSCA section 4(h)(2)
statutory requirements; (2) transparency
for stakeholders regarding EPA’s process
of hazard identification of eye irritation
and corrosion for new chemical
submissions; (3) clear scientific
rationale for identification of eye
irritation and corrosion hazards for
human health assessors leading to
improved consistency across final new
chemical risk assessments; and (4) use
of the most reproducible, humanrelevant scientific data for decisionmaking.
III. Does this Framework impose
binding requirements?
This document is not binding on the
Agency or any outside parties, and the
Agency may depart from it where
circumstances warrant and without
prior notice. While EPA has made every
effort to ensure the accuracy of the
discussion in the Framework, the
obligations of EPA and the regulated
community are determined by statutes,
regulations, or other legally binding
documents. In the event of a conflict
between the discussion in the
Framework document and any statute,
regulation, or other legally binding
document, the Framework document
will not be controlling.
IV. Is this Framework subject to the
Paperwork Reduction Act (PRA)?
This action does not contain any new
or revised information collections or
burden subject to additional OMB
approval under the PRA, 44 U.S.C. 3501
et seq. Burden is defined in 5 CFR
1320.3(b). Information collection
activities contained in the TSCA new
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
chemicals program are already approved
by OMB under the PRA and are
assigned OMB Control No. 2070–0038
(EPA ICR No. 1188.14).
Authority: 15 U.S.C. 2604 et seq.
Dated: January 3, 2024.
Michal Freedhoff,
Assistant Administrator, Office of Chemical
Safety and Pollution Prevention.
[FR Doc. 2024–00169 Filed 1–8–24; 8:45 am]
BILLING CODE P
FEDERAL DEPOSIT INSURANCE
CORPORATION
Sunshine Act Meetings
9:30 a.m. on Friday,
January 5, 2024.
PLACE: The meeting was held via video
conference on the internet.
STATUS: Closed.
MATTERS TO BE CONSIDERED: The Special
Review Committee of the Federal
Deposit Insurance Corporation met to
consider matters related to the
Corporation’s corporate activities within
its authority to act on behalf of the
Federal Deposit Insurance Corporation.
In calling the meeting, the Special
Review Committee determined, by the
unanimous vote of Director Jonathan P.
McKernan and Director Michael J. Hsu
(Acting Comptroller of the Currency),
that Corporation business required its
consideration of the matters which were
to be the subject of this meeting on less
than seven days’ notice to the public;
that no earlier notice of the meeting was
practicable; that the public interest did
not require consideration of the matters
in a meeting open to public observation;
and that the matters could be
considered in a closed meeting by
authority of subsections (c)(2) and (c)(4)
of the ‘‘Government in the Sunshine
Act’’ (5 U.S.C. 552b(c)(2) and (c)(4)).
CONTACT PERSON FOR MORE INFORMATION:
Requests for further information
concerning the meeting may be directed
to Debra A. Decker, Executive Secretary
of the Corporation, at 202–898–8748.
TIME AND DATE:
Dated: January 5, 2024.
Federal Deposit Insurance Corporation.
James P. Sheesley,
Assistant Executive Secretary.
[FR Doc. 2024–00333 Filed 1–5–24; 4:15 pm]
BILLING CODE 6714–01–P
FEDERAL RESERVE SYSTEM
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
The companies listed in this notice
have applied to the Board for approval,
E:\FR\FM\09JAN1.SGM
09JAN1
]]>Agencies
[Federal Register Volume 89, Number 6 (Tuesday, January 9, 2024)]
[Notices]
[Page 1094]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-00333]
=======================================================================
-----------------------------------------------------------------------
FEDERAL DEPOSIT INSURANCE CORPORATION
Sunshine Act Meetings
TIME AND DATE: 9:30 a.m. on Friday, January 5, 2024.
PLACE: The meeting was held via video conference on the internet.
STATUS: Closed.
MATTERS TO BE CONSIDERED: The Special Review Committee of the Federal
Deposit Insurance Corporation met to consider matters related to the
Corporation's corporate activities within its authority to act on
behalf of the Federal Deposit Insurance Corporation. In calling the
meeting, the Special Review Committee determined, by the unanimous vote
of Director Jonathan P. McKernan and Director Michael J. Hsu (Acting
Comptroller of the Currency), that Corporation business required its
consideration of the matters which were to be the subject of this
meeting on less than seven days' notice to the public; that no earlier
notice of the meeting was practicable; that the public interest did not
require consideration of the matters in a meeting open to public
observation; and that the matters could be considered in a closed
meeting by authority of subsections (c)(2) and (c)(4) of the
``Government in the Sunshine Act'' (5 U.S.C. 552b(c)(2) and (c)(4)).
CONTACT PERSON FOR MORE INFORMATION: Requests for further information
concerning the meeting may be directed to Debra A. Decker, Executive
Secretary of the Corporation, at 202-898-8748.
Dated: January 5, 2024.
Federal Deposit Insurance Corporation.
James P. Sheesley,
Assistant Executive Secretary.
[FR Doc. 2024-00333 Filed 1-5-24; 4:15 pm]
BILLING CODE 6714-01-P
